{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "regularMarketChangePercent": 0.0, "regularMarketPrice": 10.4, "exchange": "PNK", "shortName": "SINO BIOPHARMACEUTICAL UNSP ADR", "longName": "Sino Biopharmaceutical Limited", "messageBoardId": "finmb_7654965", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "bookValue": 32.22, "fiftyDayAverage": 10.6307, "fiftyDayAverageChange": -0.2307005, "fiftyDayAverageChangePercent": -0.021701345, "twoHundredDayAverage": 10.748887, "twoHundredDayAverageChange": -0.34888744, "twoHundredDayAverageChangePercent": -0.032458007, "marketCap": 9834073088, "priceToBook": 0.32278085, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "trailingAnnualDividendRate": 0.106, "trailingPE": 29.714285, "trailingAnnualDividendYield": 0.010192308, "epsTrailingTwelveMonths": 0.35, "sharesOutstanding": 940460992, "firstTradeDateMilliseconds": 1504618200000, "priceHint": 2, "regularMarketChange": 0.0, "regularMarketTime": 1683898209, "regularMarketDayHigh": 10.4, "regularMarketDayRange": "10.4 - 10.4", "regularMarketDayLow": 10.4, "regularMarketVolume": 545, "regularMarketPreviousClose": 10.4, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Other OTC", "financialCurrency": "CNY", "regularMarketOpen": 10.4, "averageDailyVolume3Month": 1266, "averageDailyVolume10Day": 7036, "fiftyTwoWeekLowChange": 1.1799994, "fiftyTwoWeekLowChangePercent": 0.12798257, "fiftyTwoWeekRange": "9.22 - 12.76", "fiftyTwoWeekHighChange": -2.3600006, "fiftyTwoWeekHighChangePercent": -0.18495302, "fiftyTwoWeekLow": 9.22, "fiftyTwoWeekHigh": 12.76, "dividendDate": 1665619200, "marketState": "PRE", "displayName": "Sino Biopharmaceutical", "symbol": "SBHMY"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Unit 09, Office Tower", "address2": "41st Floor, Room 4109 Convention Plaza 1 Harbour Road", "city": "Wan Chai", "country": "Hong Kong", "phone": "852 2802 9886", "fax": "852 2880 0847", "website": "https://www.sinobiopharm.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection. It also provides surgery/analgesia medicines comprising Debaian cataplasms and Gaisanchun soft capsules; and cardio-cerebral vascular medicines, including Yilunping and Kaina tablets. In addition, the company is involved in the long term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.", "fullTimeEmployees": 26272, "companyOfficers": [{"maxAge": 1, "name": "Ms. Y. Y.  Tse", "age": 30, "title": "Exec. Chairwoman of the Board", "yearBorn": 1992, "fiscalYear": 2021, "totalPay": {"raw": 5047574, "fmt": "5.05M", "longFmt": "5,047,574"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eric S. Y.  Tse", "age": 26, "title": "CEO & Exec. Director", "yearBorn": 1996, "fiscalYear": 2021, "totalPay": {"raw": 3318204, "fmt": "3.32M", "longFmt": "3,318,204"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ping  Tse", "age": 70, "title": "Founder & Sr. Exec. Vice Chairman", "yearBorn": 1952, "fiscalYear": 2021, "totalPay": {"raw": 6023694, "fmt": "6.02M", "longFmt": "6,023,694"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Cheung Ling  Cheng", "age": 58, "title": "Exec. Vice Chairwoman of the Board", "yearBorn": 1964, "fiscalYear": 2021, "totalPay": {"raw": 4248486, "fmt": "4.25M", "longFmt": "4,248,486"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Mingqin  Li", "age": 63, "title": "Sr. VP & Exec. Director", "yearBorn": 1959, "fiscalYear": 2021, "totalPay": {"raw": 172434, "fmt": "172.43k", "longFmt": "172,434"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Zhoushan  Tian", "age": 58, "title": "Exec. Director", "yearBorn": 1964, "fiscalYear": 2021, "totalPay": {"raw": 260662, "fmt": "260.66k", "longFmt": "260,662"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hsin  Tse", "age": 52, "title": "Sr. VP & Exec. Director", "yearBorn": 1970, "fiscalYear": 2021, "totalPay": {"raw": 838172, "fmt": "838.17k", "longFmt": "838,172"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Chun Ling  Li", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Sean  Chen", "title": "Chief Strategy Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Orphanides  George", "title": "Chief Scientific Advisor of invoX", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 4, "boardRisk": 1, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 8, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}